Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?

References

• Sanchez-MunozFADominguez-LopezAYamamoto-FurushoJKRole cytokines in inflammatory bowel diseaseWorld J Gastroenterol200814274280428818666314
   PubMed Web of Science ®Google Scholar
• ReavenGMBanting lecture 1988. Role of insulin resistance in human diseaseDiabetes19883712159516073056758
   PubMed Web of Science ®Google Scholar
• HotamisligilGSPeraldiPBudavariAEllisRWhiteMFSpiegelmanBMIRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistanceScience199627152496656688571133
   PubMed Web of Science ®Google Scholar
• SethiJKHotamisligilGSThe role of TNF alpha in adipocyte metabolismSemin Cell Dev Biol1999101192910355025
   PubMed Web of Science ®Google Scholar
• TilgHMoschenARInflammatory mechanisms in the regulation of insulin resistanceMol Med2008143–422223118235842
   PubMed Web of Science ®Google Scholar
• Al-DokhiLMAdipokines and etiopathology of metabolic disordersSaudi Med J20093091123113219750255
   PubMed Web of Science ®Google Scholar
• KredelLISiegmundBAdipose-tissue and intestinal inflammation – visceral obesity and creeping fatFront Immunol2014546225309544
   PubMed Web of Science ®Google Scholar
• SiegmundBLehrHAFantuzziGLeptin: a pivotal mediator of intestinal inflammation in miceGastroenterology200212272011202512055606
   PubMed Web of Science ®Google Scholar
• SitaramanSLiuXCharrierLColonic leptin: source of a novel proinflammatory cytokine involved in IBDFASEB J200418669669814977884
   PubMed Web of Science ®Google Scholar
• OteroMLagoRGomezRTowards a pro-inflammatory and immunomodulatory emerging role of leptinRheumatology200645894495016720637
   PubMed Web of Science ®Google Scholar
• GrunfeldCZhaoCFullerJEndotoxin and cytokines induce expression of leptin, the ob gene product, in hamstersJ Clin Invest1996979215221578621806
   PubMed Web of Science ®Google Scholar
• PlattTLBeckettTLKohlerKNiedowiczDMMurphyMPObesity, diabetes, and leptin resistance promote tau pathology in a mouse model of diseaseNeuroscience201631516217426701291
   PubMed Web of Science ®Google Scholar
• NishiharaTMatsudaMArakiHEffect of adiponectin on murine colitis induced by dextran sulfate sodiumGastroenterology2006131385386116952554
   PubMed Web of Science ®Google Scholar
• ValentiniLWirthEKSchweizerUCirculating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel diseaseNutrition200925217218118849144
   PubMed Web of Science ®Google Scholar
• RodriguesVSMilanskiMFagundesJJSerum levels and mesenteric fat tissue expression of adiponectin and leptin in patients with Crohn’s diseaseClin Exp Immunol2012170335836423121676
   PubMed Web of Science ®Google Scholar
• WalugaMHartlebMBoryczkaGKuklaMZwirska-KorczalaKSerum adipokines in inflammatory bowel diseaseWorld J Gastroenterol201420226912691724944482
   PubMed Web of Science ®Google Scholar
• ChouliarasGPanayotouIMargoniDCirculating leptin and adiponectin and their relation to glucose metabolism in children with Crohn’s disease and ulcerative colitisPediatr Res201374442042623823177
   PubMed Web of Science ®Google Scholar
• KarmirisKKoutroubakisIEXidakisCPolychronakiMVoudouriTKouroumalisEACirculating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel diseaseInflamm Bowel Dis200612210010516432373
   PubMed Web of Science ®Google Scholar
• StatnickMABeaversLSConnerLJDecreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetesInt J Exp Diabetes Res200012818811469400
   PubMedGoogle Scholar
• HugCLodishHFThe role of the adipocyte hormone adiponectin in cardiovascular diseaseCurr Opin Pharmacol20055212913415780820
   PubMed Web of Science ®Google Scholar
• MatthewsDRHoskerJPRudenskiASNaylorBATreacherDFTurnerRCHomeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia19852874124193899825
   PubMed Web of Science ®Google Scholar
• CapristoEMingroneGAddoloratoGGrecoAVGasbarriniGGlucose metabolism and insulin sensitivity in inactive inflammatory bowel diseaseAliment Pharmacol Ther199913220921710102952
   PubMed Web of Science ®Google Scholar
• NagahoriMHyunSBTotsukaTPrevalence of metabolic syndrome is comparable between inflammatory bowel disease patients and the general populationJ Gastroenterol201045101008101320414788
   PubMed Web of Science ®Google Scholar
• YorulmazEAdaliGYorulmazHUlasogluCTasanGTuncerIMetabolic syndrome frequency in inflammatory bowel diseasesSaudi J Gastroenterol201117637638222064334
   PubMed Web of Science ®Google Scholar
• BregenzerNHartmannAStrauchUSchölmerichJAndusTBollheimerLCIncreased insulin resistance and beta cell activity in patients with Crohn’s diseaseInflamm Bowel Dis2006121535616374259
   PubMed Web of Science ®Google Scholar
• DagliNPoyrazogluOKDagliAFIs inflammatory bowel disease a risk factor for early atherosclerosis?Angiology201061219820419398421
   PubMed Web of Science ®Google Scholar
• HottaKFunahashiTBodkinNLCirculating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeysDiabetes20015051126113311334417
   PubMed Web of Science ®Google Scholar
• RyoMNakamuraTKiharaSAdiponectin as a biomarker of the metabolic syndromeCirc J2004681197598115502375
   PubMed Web of Science ®Google Scholar
• DaimonMOizumiTSaitohTFunagata StudyDecreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: the Funagata studyDiabetes Care20032672015202012832305
   PubMed Web of Science ®Google Scholar
• SnehalathaCMukeshBSimonMViswanathanVHaffnerSMRamachandranAPlasma adiponectin is an independent predictor of type 2 diabetes in Asian IndiansDiabetes Care200326123226322914633806
   PubMed Web of Science ®Google Scholar
• YamauchiTKamonJWakiHThe fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesityNat Med20017894194611479627
   PubMed Web of Science ®Google Scholar
• SaxenaAFletcherELarsenBBaligaMSDurstineJLFayadREffect of exercise on chemically-induced colitis in adiponectin deficient miceJ Inflamm20122130
   Google Scholar
• GoveMEPiniMFayadRCabayRJFantuzziGAdiponectin deficiency modulates adhesion molecules expression and cytokine production but does not affect disease severity in the transfer model of colitisCytokine200947211912519520591
   PubMed Web of Science ®Google Scholar
• YamamotoKKiyoharaTMurayamaYProduction of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn’s diseaseGut200554678979615888786
   PubMed Web of Science ®Google Scholar
• WeigertJObermeierFNeumeierMCirculating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn’s diseaseInflamm Bowel Dis201016463063719714754
   PubMed Web of Science ®Google Scholar
• BarbierMVidalHDesreumauxPOverexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseasesGastroenterol Clin Biol20032798799114732844
   PubMed Web of Science ®Google Scholar
• BarrenetxeJVillaroACGuembeLDistribution of the long leptin receptor isoform in brush border, basolateral membrane, and cytoplasm of enterocytesGut200250679780212010881
   PubMed Web of Science ®Google Scholar
• TuzunAUygunAYesilovaZLeptin levels in the acute stage of ulcerative colitisJ Gastroenterol Hepatol200419442943215012781
   PubMed Web of Science ®Google Scholar
• NishiYIsomotoHUenoHPlasma leptin and ghrelin concentrations in patients with Crohn’s diseaseWorld J Gastroenterol200511467314731716437634
   PubMed Web of Science ®Google Scholar
• GhomraouiFAAlotaibiSTAlharthiMAPlasma ghrelin and leptin in patients with inflammatory bowel disease and its association with nutritional statusSaudi J Gastroenterol201723319920528611344
   PubMed Web of Science ®Google Scholar